Notably, Th17 cells play a dual role in the tumour microenvironment, promoting tumour progression via immunosuppressive and pro‐angiogenic pathways, yet also mediating anti‐tumour effects through Th1‐like conversion and IFN‐γ production [33, 34]. The gene discussed is IFNG; the disease is neoplasm.